Sources familiar with the issue say FDA may soon make a decision to authorize emergency use of blood plasma from recovered COVID-19 patients for treating those infected with the disease. Some physicians and hospitals already treat hospitalized COVID-19 patients with convalescent plasma under compassionate use and as part of studies.
Sources familiar with the issue say FDA may soon make a decision to authorize emergency use of blood plasma from recovered COVID-19 patients for treating those infected with the disease. Some physicians and hospitals already treat hospitalized COVID-19 patients with convalescent plasma under compassionate use and as part of studies…
